Further processing options
Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT^|^#174; technology
Saved in:
Journal Title: | Folia Pharmacologica Japonica |
---|---|
Authors and Corporations: | |
In: | Folia Pharmacologica Japonica, 142, 2013, 4, p. 167-171 |
Type of Resource: | E-Article |
Language: | English |
published: |
Japanese Pharmacological Society
|
Subjects: |